LINC02086 promotes cell viability and inhibits cell apoptosis in breast cancer by sponging miR-6757-5p and up-regulating EPHA2

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20:417–36.

Article  CAS  PubMed  Google Scholar 

Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed Res Int. 2022;2022:9605439.

Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 2022;83:1–7.

Article  PubMed  Google Scholar 

Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95:20211033.

Article  PubMed  Google Scholar 

Lin W, Zhou Q, Wang CQ, et al. LncRNAs regulate metabolism in cancer. Int J Biological Sciences. 2020;16:1194–206.

Article  CAS  Google Scholar 

Sideris N, Dama P, Bayraktar S, et al. LncRNAs in breast cancer: a link to future approaches. Cancer Gene Ther. 2022;29:1866–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han JJ, Wang XQ, Zhang XA. Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis. Frontiers Immunol. 2022;13:1–17.

Google Scholar 

Venkatesh J, Wasson MD, Brown JM, et al. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack. Cancer letters. 2021;509:81–8.

Article  CAS  PubMed  Google Scholar 

Ghafouri-Fard S, Glassy MC, Abak A, et al. The interaction between miRNAs/lncRNAs and Notch pathway in human disorders. Biomedicine Pharmacotherapy Biomedecine Pharmacotherapie. 2021;138:1–14.

Google Scholar 

Shi Y, Yang D, Qin Y. Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma. BMC Cancer. 2021;21:705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye J, Li H, Wei J, Luo Y, Liu H, Zhang J, Luo X. Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis. Asian Pac J Cancer Prev. 2020;21:1787–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson K, Shiuan E, Brantley-Sieders DM. Oncogenic functions and therapeutic targeting of EphA2 in cancer. Oncogene. 2021;40:2483–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao P, Jiang D, Huang Y, et al. EphA2: A promising therapeutic target in breast cancer. J Genet Genomics. 2021;48:261–7.

Article  CAS  PubMed  Google Scholar 

Zaghlool A, Niazi A, Björklund ÅK, et al. Characterization of the nuclear and cytosolic transcriptomes in human brain tissue reveals new insights into the subcellular distribution of RNA transcripts. Scientific reports. 2021;11:1–14.

Article  Google Scholar 

Li W, Ye K, Li X, Liu X, Peng M, Chen F, Xiong W, Wang Y, Zhu L. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. J Exp Clin Cancer Res. 2022;41:250.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng C, Yuan G, Hu Y, et al. Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Bioengineered. 2022;13:1491–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller K, Ogris M, Sami H. Firefly Luciferase-Based Reporter Gene Assay for Investigating Nanoparticle-Mediated Nucleic Acid Delivery. Methods Mol Biol. 2019;1943:227–39.

Article  PubMed  Google Scholar 

Liu J, Xue N, Guo Y, et al. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway. Aging. 2019;11:12412–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang X, Wang G, Liu Y, et al. A novel long non-coding RNA RP11–286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. Cancer letters. 2021;499:109–21.

Article  CAS  PubMed  Google Scholar 

Shakeri A, Hafezian T, Kúsz N, et al. Cytotoxicity, apoptosis inducing activity and Western blot analysis of tanshinone derivatives from Stachys parviflora on prostate and breast cancer cells. Molecular Biology Reports. 2022;49:8251–8.

Article  CAS  PubMed  Google Scholar 

Okuyama T, Sakamoto R, Kumagai K, et al. EPHA2 antisense RNA modulates EPHA2 mRNA levels in basal-like/triple-negative breast cancer cells. Biochimie. 2020;179:169–80.

Article  CAS  PubMed  Google Scholar 

Xiao, T., Xiao, Y., Wang, W., et al. (2020) Targeting EphA2 in cancer. Journal of hematology & oncology13, 1–17

Najafi S, Khatami SH, Khorsand M, et al. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis. Experimen Cell Res. 2022;418:1–13.

Google Scholar 

Han X, Mo J, Yang Y, et al. Crucial Roles of LncRNAs-Mediated Autophagy in Breast Cancer. Int J Medical Scie. 2022;19:1082–92.

Article  CAS  Google Scholar 

Shen Y, Peng X, Shen C. Identification and validation of immune-related lncRNA prognostic signature for breast cancer. Genomics. 2020;112:2640–6.

Article  CAS  PubMed  Google Scholar 

Li N, Su M, Zhu L, Wang L, Peng Y, Dong B, Ma L, Liu Y. A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma. Int J Gen Med. 2021;14:8955–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamb CA, Vanzulli SI, Lanari C. Hormone receptors in breast cancer: more than estrogen receptors. Medicina. 2019;79:540–5.

CAS  PubMed  Google Scholar 

Nagaraj G, Ma CX. Clinical challenges in the management of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: a literature review. Advances in therapy. 2021;38:109–36.

Article  CAS  PubMed  Google Scholar 

Saw PE, Xu X, Chen J, et al. Non-coding RNAs: the new central dogma of cancer biology. Scie China Life Scie. 2021;64:22–50.

Article  CAS  Google Scholar 

Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65:625–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et biophysica acta. Reviews Cancer. 2021;1875:1–18.

Google Scholar 

Murata M, Marugame Y, Morozumi M, Murata K, Kumazoe M, Fujimura Y, Tachibana H. (-)-Epigallocatechin-3-O-gallate upregulates the expression levels of miR-6757-3p, a suppressor of fibrosis-related gene expression, in extracellular vesicles derived from human umbilical vein endothelial cells. Biomed Rep. 2023;18:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Z, Han X, Zhu Y, Zhang H, Tian R, Wang Z, Cui Y, Wang Z, Niu R, Zhang F. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling. Cell Death Dis. 2021;12:414.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Li Y, Chen C, et al. Exosomal EphA2 promotes tumor metastasis of triple-negative breast cancer by damaging endothelial barrier. Clinical Experimen Metastasis. 2023;40:105–16.

Article  CAS  Google Scholar 

Zhou L, Lu X, Zhang B, et al. EphA2 as a new target for breast cancer and its potential clinical application. Intern J Clinical Experimen Pathology. 2021;14:484–92.

CAS  Google Scholar 

Han B, Zhang H, Tian R, et al. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Theranostics. 2022;12:4127–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai T, Liu Y, Cao R, et al. CBX7 regulates metastasis of basal-like breast cancer through Twist1/EphA2 pathway. Translational oncology. 2022;24:1–12.

Article  Google Scholar 

Psilopatis I, Souferi-Chronopoulou E, Vrettou K, Troungos C, Theocharis S. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy. Int J Mol Sci. 2022;23:15275.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif